Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Comparative, Multicenter, Randomized Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation

NCT00811915 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT00811915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00811915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Comparative, Multicenter, Randomized Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2009
Completion date
June 30, 2014
Enrollment
65 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation